Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2000 / Cilt: 5 - Sayı: 3

Ventilator associated pneumonia cases in the postoperative intensive care unit of a cardiothoracic surgery center

Kardiyotorasik cerrahi postoperatif yoğun bakım ünitesinde izlenen ventilatörle ilgili pnömoniler

Pages
183–188
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Crude mortality rate of VAP was calculated as 30%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ventilator associated pneumonia (VAP) cases were investigated in a cardiothoracic surgery postoperati¬ve intensive care unit between I January 1999 and I January 2000.
📊
Key Findings & Data:A total of 1716 patients who undergone cardiothoracic operations and followed in intensive care unit (ICU) were included in the study.
💡
Conclusion & Impact:Crude mortality rate of VAP was calculated as 30%.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Yoğun bakım üniteleri · Ölüm oranı · Pnömoni

Abstract

Ventilator associated pneumonia (VAP) cases were investigated in a cardiothoracic surgery postoperati¬ve intensive care unit between I January 1999 and I January 2000. A total of 1716 patients who undergone cardiothoracic operations and followed in intensive care unit (ICU) were included in the study. Patient and laboratory based prospective surveillance study of VAP was done along with other hospital acquired infecti¬ons. During the study period, a total of 26585 patient days with 2708 ventilator days were determined. 46 cases of VAP were founded in 36 of 1716 patients who undergone cardiothoracic operations (2.09%, 1.3 pne¬umonia/patient). Ventilator utilization rate at our institution was found to be 0.10. There were 16.4 VAP's per 1000 ventilation days.38% of VAP were caused by gram-negative enteric rods (27% Enterobacter spp., 8% Klebsiella spp., 3% Serratia spp.), 34% by Pseudomonas aeruginosa, 17% by Staphylococcus aureus. VAP was polymicrobial in 9% of cases. No causative microorganism was identified in 2% of cases. Same bacteria were isolated both in blood and endotracheal aspirate cultures in 10 of 46 pneumonia cases (22%). Crude mortality rate of VAP was calculated as 30%.

Özet

Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Hastanesi, Postoperatif Yoğun Bakım Ünitesi'nde I Ocak 1999-1 Ocak 2000 tarihleri arasında gözlenen ventilatörle ilgili pnömoni (VİP) olguları değerlendirilmiş¬tir. Kardiyotorasik operasyon geçiren ve postoperatif yoğun bakım ünitesinde izlenen toplam 1716 hasta ça¬lışmaya dahil edilmiştir. VİP olgularının sürveyansı, prospektif, hastaya ve laboratuvara dayalı olarak yapılmış¬tır. Çalışma süresi boyunca toplam 26585 hasta gününde 2708 ventilator günü belirlenmiştir. Binyediyüzonal-tı hastanın 36'sında toplam 46 pnömoni atağı saptanmıştır (%2.09, 1.3 pnömoni/hasta). Ünitemizde ventilator kullanım oranı 0.10 olarak hesaplanmış, 1000 ventilasyon gününde 16.4 VİP atağı olduğu belirlenmiştir. VİP ataklarının %38'inde etken mikroorganizma gram-negatif enterik çomaklar (%27 Enterobacter spp., %8 Kleb¬siella spp., %3 Serratia spp.), %34'ünde Pseudomonas aeruginosa ve % 17'sinde Staphylococcus aureus olarak belirlenmiştir. Atakların %9'unda polimikrobiyal etyoloji sözkonusu olup, %2'sinde etken mikroorganizma izo¬le edilememiştir. Olguların %22'sinde endotrakeal aspirat kültüründen izole edilen mikroorganizma kan kül¬türünden de izole edilmiştir. VİP olgularında kaba mortalite oranı %30 olarak belirlenmiştir.

🔖

Cite This Article

ŞİMŞEK, S., YURTSEVEN, N., GERÇEKOĞLU, H., SOHTORİK, Ü., CANİK, S., ÖZLER, A. (2000). Ventilator associated pneumonia cases in the postoperative intensive care unit of a cardiothoracic surgery center. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 5 - Sayı: 3, 183–188. https://ajindex.com/articles/224371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. CDC, Guidelines for prevention of nosocomial pneumoniae. MMWR 1997;46(RR-1):1-79
  2. Garner J, Jarwis W, Emori G, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 3:128-40
  3. CDC, NNIS System Report, data summary from October 1986-April 1997. AJIC Am J Infect Control 1997;25: 477-87
  4. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests (Approved Standard, M2-A5). Villanova, PA, National Committee for Clinical Laboratory Standards, 1993
  5. Wiblin T. Nosocomial pneumoniae. In: Wenzel R (ed). Prevention and Control of Nosocomial Infections. 3rd ed, Baltimore: Williams-Wilkins, 1997:807-20
  6. Mayhall G. Nosocomial pneumoniae. Infect Dis Clin North America 1997;11:427-57
  7. Weber D, Raasch R, Rutala W. Nosocomial infections in the ICU. Chest 1999;115:34-41
  8. Uzel S, Özsüt Ö, Eraksoy H ve ark. Yoğun bakım biriminde ventilatörle ilişkili pnömoni etkeni olabilecek bakterilerin dağılımı ve antibiyotiklere duyarlılıkları. Klimik Derg 1996;9:6-9
  9. Akalın H, Özakın C, Kahveci F. Hastane kökenli pnömoniler. Flora 1999;4:253-7
  10. Snydman D. Clinical implications of multi-drug resistance in the ICU. Scand J Infect Dis 1991;Suppl 78(-HD-):54- 63
  11. Chastre J, Fagon JY, Trouillet JL. Diagnosis and treatment of nosocomial pneumoniae in patients in intensive care units. Clin Infect Dis 1995;21:226-37
  12. Kollef MH. Empiric antibiotic selection and outcome in patients with suspected nosocomial pneumoniae. Veterans Health System Journal 1999, January
  13. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:196- 200
  14. Rello J, Sa-Borges M, Correa H, et al. Am J Respir Crit Care Med 1999;160:608-13
  15. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-20.